TY  - GEN
AU  - Antunes, Liliana
AU  - Mazagatos, Clara
AU  - Martínez-Baz, Iván
AU  - Gomez, Verónica
AU  - Borg, Maria-Louise
AU  - Petrović, Goranka
AU  - Duffy, Róisín
AU  - Dufrasne, François E
AU  - Dürrwald, Ralf
AU  - Lazar, Mihaela
AU  - Jancoriene, Ligita
AU  - Oroszi, Beatrix
AU  - Husa, Petr
AU  - Howard, Jennifer
AU  - Melo, Aryse
AU  - Pozo Sanchez, Francisco
AU  - Pérez-Gimeno, Gloria
AU  - Castilla, Jesús
AU  - Machado, Ausenda
AU  - Džiugytė, Aušra
AU  - Karabuva, Svjetlana
AU  - Fitzgerald, Margaret
AU  - Fierens, Sébastien
AU  - Tolksdorf, Kristin
AU  - Popovici, Silvia-Odette
AU  - Mickiene, Aukse
AU  - Túri, Gergő
AU  - Součková, Lenka
AU  - Nicolay, Nathalie
AU  - Rose, Angela Mc
AU  - European Hospital Vaccine Effectiveness Group
PY  - 2024
DO  - 10.2807/1560-7917.ES.2024.29.3.2300708
UR  - http://hdl.handle.net/20.500.12105/18998
AB  - We conducted a multicentre hospital-based test-negative case-control study to measure the effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS-CoV-2 infection during the Omicron XBB lineage-predominant period in patients...
LA  - eng
PB  - European Centre for Disease Prevention and Control (ECDC)
KW  - COVID-19
KW  - COVID-19 bivalent vaccines
KW  - Europe
KW  - Hospitalisation
KW  - SARI
KW  - SARS-CoV-2
KW  - Vaccine effectiveness
KW  - XBB
KW  - COVID-19 Vaccines
KW  - COVID-19
KW  - Humans
KW  - Case-Control Studies
KW  - SARS-CoV-2
KW  - Hospitalization
KW  - Europe
KW  - RNA, Messenger
TI  - Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
TY  - research article
ER  -